Results of heart transplantation following failed staged palliation of hypoplastic left heart syndrome and related single ventricle anomalies

European Journal of Cardio-thoracic Surgery

Volumn 48, Issue 5, 2015, Pages 792-799

  Alsoufi, Bahaaldin ^a   Deshpande, Shriprasad ^a   McCracken, Courtney ^a   Kogon, Brian ^a   Vincent, Robert ^a   Mahle, William ^a   Kanter, Kirk ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart transplantation; Hypoplastic left heart syndrome; Norwood

Indexed keywords

PANEL REACTIVE ANTIBODY;

ARTICLE; CAUSE OF DEATH; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; FONTAN PROCEDURE; GLENN SHUNT; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWOOD PROCEDURE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETRANSPLANTATION; RISK FACTOR; SCHOOL CHILD; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME; FOLLOW UP; NEWBORN; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INFANT, NEWBORN; MALE; NORWOOD PROCEDURES; PALLIATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84946715587     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu547     Document Type: Article

References (25)

1. Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT et al. Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol 2012;59(1 Suppl):S1-42.
2. Alsoufi B, Bennetts J, Verma S, Caldarone CA. New developments in the treatment of hypoplastic left heart syndrome. Pediatrics 2007;119:109-17.
3. Everitt MD, Boyle GJ, Schechtman KB, Zheng J, Bullock EA, Kaza AK et al. Early survival after heart transplant in young infants is lowest after failed single-ventricle palliation: a multi-institutional study. J Heart Lung Transplant 2012;31:509-16.
4. Chrisant MR, Naftel DC, Drummond-Webb J, Chinnock R, Canter CE, Boucek MM et al. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant 2005;24:576-82.
5. Murtuza B, Dedieu N, Vazquez A, Fenton M, Burch M, Hsia TY et al. Results of orthotopic heart transplantation for failed palliation of hypoplastic left heart. Eur J Cardiothorac Surg 2013;43:597-603.
6. Tweddell JS, Sleeper LA, Ohye RG, Williams IA, Mahony L, Pizarro C et al. Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: risk factors and their interaction with shunt type. J Thorac Cardiovasc Surg 2012;144:152-9.
7. Newburger JW, Sleeper LA, Frommelt PC, Pearson GD, Mahle WT, Chen S et al. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation 2014;129:2013-20.
8. Jacobs JP, Asante-Korang A, O'Brien SM, Chai PJ, Dadlani GH, Rodriguez-Fazzi GL et al. Lessons learned from 119 consecutive cardiac transplants for pediatric and congenital heart disease. Ann Thorac Surg 2011;91:1248-54.
9. Dionigi B, Razzouk AJ, Hasaniya NW, Chinnock RE, Bailey LL. Late outcomes of pediatric heart transplantation are independent of pretransplant diagnosis and prior cardiac surgical intervention. J Heart Lung Transplant 2008;27:1090-5.
10. Marx GR, Shirali G, Levine JC, Guey LT, Cnota JF, Baffa JM et al. Multicenter study comparing shunt type in the Norwood procedure for singleventricle lesions: three-dimensional echocardiographic analysis. Circ Cardiovasc Imaging 2013;6:934-42.
11. Nathan M, Sleeper LA, Ohye RG, Frommelt PC, Caldarone CA, Tweddell JS et al. Technical performance score is associated with outcomes after the Norwood procedure. J Thorac Cardiovasc Surg 2014;148(5):2208-14.
12. Davies RR, Sorabella RA, Yang J, Mosca RS, Chen JM, Quaegebeur JM. Outcomes after transplantation for 'failed' Fontan: a single-institution experience. J Thorac Cardiovasc Surg 2012;143:1183-92.
13. Voeller RK, Epstein DJ, Guthrie TJ, Gandhi SK, Canter CE, Huddleston CB. Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients. Ann Thorac Surg 2012; 94:807-15.
14. Kanter KR, Mahle WT, Vincent RN, Berg AM, Kogon BE, Kirshbom PM. Heart transplantation in children with a Fontan procedure. Ann Thorac Surg 2011;91:823-30.
15. Kovach JR, Naftel DC, Pearce FB, Tresler MA, Edens RE, Shuhaiber JH et al. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant 2012;31:133-9.
16. Iyengar AJ, Sharma VJ, Weintraub RG, Shipp A, Brizard CP, d'Udekem Y et al. Surgical strategies to facilitate heart transplantation in children after failed univentricular palliations: the role of advanced intraoperative surgical preparation. Eur J Cardiothorac Surg 2014;46:480-5.
17. Chen JM, Davies RR, Mital SR, Mercando ML, Addonizio LJ, Pinney SP et al. Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann Thorac Surg 2004;78:1352-61.
18. Almond CS, Gauvreau K, Canter CE, Rajagopal SK, Piercey GE, Singh TP. A risk-prediction model for in-hospital mortality after heart transplantation in US children. Am J Transplant 2012;12:1240-8.
19. Dipchand AI, Kirk R, Mahle WT, Tresler MA, Naftel DC, Pahl E et al. Ten yr of pediatric heart transplantation: a report from the Pediatric Heart Transplant Study. Pediatr Transplant 2013;17:99-111.
20. Kansara P, Czer L, Awad M, Arabia F, Mirocha J, De Robertis M et al. Heart transplantation with and without prior sternotomy: analysis of the United Network for Organ Sharing database. Transplant Proc 2014;46:249-55.
21. Helmschrott M, Beckendorf J, Akyol C, Ruhparwar A, Schmack B, Erbel C et al. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. Drug Des Devel Ther 2014;8:1307-14.
22. Mahle WT, Tresler MA, Edens RE, Rusconi P, George JF, Naftel DC et al. Allosensitization and outcomes in pediatric heart transplantation. J Heart Lung Transplant 2011;30:1221-7.
23. Holt DB, Lublin DM, Phelan DL, Boslaugh SE, Gandhi SK, Huddleston CB et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007;26: 876-82.
24. Wright EJ, Fiser WP, Edens RE, Frazier EA, Morrow WR, Imamura M et al. Cardiac transplant outcomes in pediatric patients with pre-formed antihuman leukocyte antigen antibodies and/or positive retrospective crossmatch. J Heart Lung Transplant 2007;26:1163-9.
25. Morrow WR, Frazier EA, Mahle WT, Harville TO, Pye SE, Knecht KR et al. Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients. Transplantation 2012;93:319-24.